F. Danel et al., OXA-14, ANOTHER EXTENDED-SPECTRUM VARIANT OF OXA-10 (PSE-2) BETA-LACTAMASE FROM PSEUDOMONAS-AERUGINOSA, Antimicrobial agents and chemotherapy, 39(8), 1995, pp. 1881-1884
Pseudomonas aeruginosa 455, isolated in Ankara, Turkey, produced a pI
6.2 beta-lactamase determined by plasmid pMLH53 and resisted all beta-
lactams except carbapenems. This beta-lactamase, named OXA-14, corresp
onded to OXA-10 (PSE-2) except that aspartate replaced glycine at posi
tion 157 and thus is intermediate between OXA-10 and OXA-11, which has
aspartate at position 157 and a further substitution at position 143.